Germany | BCH-RA-DE-111657 | Risk Assessment generated by a regulatory process | Biosafety Clearing-House

Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-111657-3   |   PDF   |   Print   |  
published: 22 Feb 2017 last updated: 23 Nov 2020
General Information
6786-01-0085 (adv. 42010-0085) Summary of the risk assessment of a deliberate release (field trial) of genetically modified maize (Zea mays), offspring of T25, issued by the German Competent Authority
EN
14 May 1998
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
1 field site in Germany, for details refer to the German LMO/GMO location register (https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
EURL-GMFF:
Status of Dossiers see Dossier with validation completed, Event T25 (http://gmo-crl.jrc.ec.europa.eu/StatusOfDossiers.aspx)

JRC:
QT-EVE-ZM-011 (http://gmo-crl.jrc.ec.europa.eu/gmomethods/entry?db=gmometh&id=qt-eve-zm-011&q=ACS-ZM003-2)
Mazzara M. et al. (2013): "Event-specific Method for the Quantification of Maize Line T25 Using Real-time PCR v. 1.01 - Validation Report and Validated Method"
EN
Additional information
-   deliberate release, no placing on the market.
-   field trial, not for human consumption or for feed purposes

-  There is no Summary Notification Information Format available on the Internet (WebSNIF) for B/DE/97/85

-  The placing on the market of maize T25 as food or feed and in products other than food or feed is authorised in the EU until 24 April 2025.
EN
Loading...